Chart INR, page-270

First 270 Last

Share
Profile

Follow
Bearju

152 Posts.

16

03/08/23

06:10

Post #: 69126367
Share

Originally posted by SeizeValue: ↑

At first glance, I can identify a couple of potential reasons why both companies have experienced growth compared to Ioneer. Please note that I'm not directly involved with these companies, so my assessment is surface-level as of twenty minutes ago.

One significant aspect to consider is LRS's frequent and high-quality announcements, especially when contrasted with Ioneer's. These announcements seem to have generated considerable quarterly momentum for LRS, even without delving deep into their content.

LRS Quarterly Announcements:
12 April 2023 – Noteworthy High-Grade Colina Intersections.
19 April 2023 – Successfully raised A$37.1M to accelerate resource growth.
27 April 2023 – Appointed CFO and VP of Operations – Americas.
2 May 2023 – Diamond Drilling on Track for June Resource Update – Colina.
18 May 2023 – Confirmed Colina Lithium Pegmatites Extending Over 2KM.
7 June 2023 – Imminent Upgrade in Colina Lithium Deposit Resource.
8 June 2023 – Latin Increases Investment in Solis Minerals to 17.79%.
20 June 2023 – Impressive 241% Increase in the Colina Mineral Resource.
28 June 2023 – Confirmed New Salinas Lithium Corridor.

Ioneer Quarterly Announcements:
12 April 2023 - Reported a Change in substantial holding.
19 April 2023 - Announced a 168% Increase in Mineral Resource to 3.4Mt LCE.
27 April 2023 - Released the March 2023 Quarterly Activities Report.
27 April 2023 - Issued the March 2023 Quarterly Cash Flow Report.
2 May 2023 - Established Ioneer and Dragonfly Energy Partnership.

Regarding Leo (LLL), they are on track for commencing production in the first half of 2024, which speaks for itself compared to Ioneer's current status.

While we can anticipate some high-quality announcements from INR this month, we'll ultimately have to wait until Q1 2024 for the ROD.

Concerning the previous discussions about the DFS CapEx and OpEx, it would be reasonable to consider a fair adjustment within the range of +29% to +31%. This adjustment is based on the US PPI growth since 2020 in products and services pertinent to the project, such as the construction sector. Additionally, given that the figures are at the producer level, an additional +5% contingency should also be factored in. Ultimately, without having access to the complete DFS, it remains uncertain, and any definitive conclusion is merely speculative.

If you apply these adjustments to the previous DFS financials, you'll be pleasantly surprised by how significantly a revised average lithium price can alter the overall picture when quantified. The ability to make such substantial adjustments to the average commodity price presents an opportunity South32 needed in the zinc, lead, and silver space.

Expand

thanks

Not convinced we get a bump after permitting either

LAC is trading lower and they are fully permitted. They also got $650 million from GM for only 20pc of the project

INR Price at posting: 29.0¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 148 more messages in this thread...

First 270 Last

Add INR (ASX) to my watchlist

(20min delay)
Last 22.0¢		Change 0.015(7.32%)		Mkt cap ! $514.3M

Open	High	Low	Value	Volume
21.5¢	22.5¢	20.5¢	$662.6K	3.074M

Buyers (Bids)

No.	Vol.	Price($)
2	199999	22.0¢

Sellers (Offers)

Price($)	Vol.	No.
22.5¢	2027693	13

View Market Depth

No.	Vol.	Price($)
2	199999	0.220
6	219601	0.215
4	80262	0.210
6	683950	0.205
10	1372626	0.200

Price($)	Vol.	No.
0.225	2025193	12
0.230	294581	8
0.235	334828	8
0.240	366080	11
0.245	250653	6

Last trade - 16.10pm 07/10/2024 (20 minute delay)

INR (ASX) Chart

Chart INR, page-270

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Chart INR, page-270

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News